Jai Pandey

Head, Global Device Regulatory for IVDs & Digital Health Sanofi

Seminars

Tuesday 31st March 2026
Panel Discussion: Defining a Unified Path Towards IVDR Compliance for Streamlined Approvals
5:20 pm
  • How has IVDR changed expectations for evidence generation, documentation, and timelines across regulators, notified bodies, pharma, and diagnostic developers?
  • Is there any strategy change in aligning with notified bodies and regulators?
  • What are the most common bottlenecks companies encounter during co-development; from clinical trials to MAA and conformity assessment?
Tuesday 31st March 2026
Chaired by:
Jain Pandey Speaker at 16th World Clinical Biomarkers & Companion Diagnostics Summit Europe